Germany
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
25.46%
|
Dec. 31, 2023 | USD 42.86 | 0.25% |
|
Germany |
|
2 |
15.08%
|
Dec. 31, 2023 | USD 55.66 | 3.14% |
|
Germany |
|
3 |
4.60%
|
Dec. 31, 2023 | USD 123.08 | 5.04% |
|
Germany |
|
4 |
-11.60%
|
Dec. 31, 2023 | USD 1.44 | 1.72% |
|
Germany |
|
5 |
-41.24%
|
Nov. 30, 2023 | USD 2.56 | 1.91% |
|
Germany |
|
6 |
-41.56%
|
Dec. 31, 2023 | USD 2.41 | 1.69% |
|
Germany |
|
7 |
-50.33%
|
Dec. 31, 2023 | USD 3.80 | 5.15% |
|
Germany |
The Vaccines company in Germany with the highest Return on Equity (ROE) is Biotest AG (XETRA: BIO.DE) at 25.46%.
The Vaccines company in Germany with the lowest Return on Equity (ROE) is CureVac N.V. (Frankfurt Stock Exchange: 5CV.F) at -50.33%.
The top 10 Vaccines companies in Germany by Return on Equity (ROE) are Biotest AG, Formycon AG, BioNTech SE, NanoRepro AG, Heidelberg Pharma AG, InflaRx N.V. and CureVac N.V..
The bottom 10 Vaccines companies in Germany by Return on Equity (ROE) are CureVac N.V., InflaRx N.V., Heidelberg Pharma AG, NanoRepro AG, BioNTech SE, Formycon AG and Biotest AG.